Effectiveness and Safety of Imatinib and Nilotinib in Chronic Myeloid Leukemia: A Single-Center Study From Southern Morocco
Cureus · 27.07.2026
DOI: 10.7759/cureus.113439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 27.07.2026. Verfasst von Mossaab El Mousadik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hematology, Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir, MAR. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology, Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir, MAR.
- Epidemiology and Clinical Research Laboratory, Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir, MAR.
- Medical and Clinical Pharmacology, Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir, MAR.
Zitieren
APA
El Mousadik, M., El Khayat, H., El Hizazi, L., Bounar, O., Halloumi, O., Fatima Ezzahra, R., Chakri, I., Bouqoufi, A., Lahlou, L., & Fares, S. (2026). Effectiveness and Safety of Imatinib and Nilotinib in Chronic Myeloid Leukemia: A Single-Center Study From Southern Morocco. Cureus. https://doi.org/10.7759/cureus.113439
Vancouver
El Mousadik M, El Khayat H, El Hizazi L, Bounar O, Halloumi O, Fatima Ezzahra R, et al. Effectiveness and Safety of Imatinib and Nilotinib in Chronic Myeloid Leukemia: A Single-Center Study From Southern Morocco. Cureus. 2026. doi:10.7759/cureus.113439
BibTeX
@article{ElMousadik2026,
author = {El Mousadik, Mossaab and El Khayat, Houda and El Hizazi, Layla and Bounar, Oumaima and Halloumi, Omar and Fatima Ezzahra, Rida and Chakri, Imad and Bouqoufi, Afaf and Lahlou, Laila and Fares, Salma},
title = {Effectiveness and Safety of Imatinib and Nilotinib in Chronic Myeloid Leukemia: A Single-Center Study From Southern Morocco},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.113439}
}
EUVIMED